NEW YORK (GenomeWeb) – Olink AB announced today that it has completed a reorganization and has split into two separate companies — Olink Proteomics and Olink Bioscience.

Olink Proteomics will continue to expand and develop the Proseek Multiplex human protein biomarker discovery product portfolio and is aiming to create a variety of high-quality multiplex immunoassays for biomarker discovery as well as diagnostic tools based on clinically relevant protein signatures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.